BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kückelhaus J, Vollmer L, Goeldner JM, Behringer SP, Scherer F, Boerries M, Follo M, Weiss T, Delev D, Kernbach J, Franco P, Schallner N, Dierks C, Carro MS, Hofmann UG, Fung C, Sankowski R, Prinz M, Beck J, Salié H, Bengsch B, Schnell O, Heiland DH. T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun 2022;13:925. [PMID: 35177622 DOI: 10.1038/s41467-022-28523-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Gorvel L, Olive D. Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammation. Seminars in Immunology 2023;65:101671. [DOI: 10.1016/j.smim.2022.101671] [Reference Citation Analysis]
2 Zhao J, Dong Y, Zhang Y, Wang J, Wang Z. Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy. Advanced Drug Delivery Reviews 2022;191:114585. [DOI: 10.1016/j.addr.2022.114585] [Reference Citation Analysis]
3 Chen F, Chao M, Huang T, Guo S, Zhai Y, Wang Y, Wang N, Xie X, Wang L, Ji P. The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1055783] [Reference Citation Analysis]
4 Perdyan A, Lawrynowicz U, Horbacz M, Kaminska B, Mieczkowski J. Integration of single-cell RNA sequencing and spatial transcriptomics to reveal the glioblastoma heterogeneity. F1000Res 2022;11:1180. [DOI: 10.12688/f1000research.126243.1] [Reference Citation Analysis]
5 Fan Z, Luo Y, Lu H, Wang T, Feng Y, Zhao W, Kim P, Zhou X. SPASCER: spatial transcriptomics annotation at single-cell resolution. Nucleic Acids Res 2022:gkac889. [PMID: 36243975 DOI: 10.1093/nar/gkac889] [Reference Citation Analysis]
6 Yu Q, Jiang M, Wu L. Spatial transcriptomics technology in cancer research. Front Oncol 2022;12:1019111. [DOI: 10.3389/fonc.2022.1019111] [Reference Citation Analysis]
7 Franson A, Mcclellan BL, Varela ML, Comba A, Syed MF, Banerjee K, Zhu Z, Gonzalez N, Candolfi M, Lowenstein P, Castro MG. Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. Front Med 2022;9. [DOI: 10.3389/fmed.2022.966458] [Reference Citation Analysis]
8 Brooks LJ, Simpson Ragdale H, Hill CS, Clements M, Parrinello S. Injury programs shape glioblastoma. Trends Neurosci 2022:S0166-2236(22)00163-1. [PMID: 36089406 DOI: 10.1016/j.tins.2022.08.006] [Reference Citation Analysis]
9 Mirzaei R, Yong VW. Microglia-T cell conversations in brain cancer progression. Trends Mol Med 2022:S1471-4914(22)00211-8. [PMID: 36075812 DOI: 10.1016/j.molmed.2022.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Picca A, Finocchiaro G. Deciphering diffuse glioma immune microenvironment as a key to improving immunotherapy results. Curr Opin Oncol 2022. [PMID: 36000367 DOI: 10.1097/CCO.0000000000000895] [Reference Citation Analysis]
11 Sun R, Kim AH. The multifaceted mechanisms of malignant glioblastoma progression and clinical implications. Cancer Metastasis Rev 2022. [PMID: 35920986 DOI: 10.1007/s10555-022-10051-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Watchmaker PB, Colton M, Pineo-Cavanaugh PL, Okada H. Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. Curr Opin Oncol 2022. [PMID: 35855503 DOI: 10.1097/CCO.0000000000000877] [Reference Citation Analysis]
13 Takacs GP, Kreiger CJ, Luo D, Tian G, Garcia JS, Deleyrolle LP, Mitchell DA, Harrison JK. Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+ myeloid cells into the tumor microenvironment in a redundant manner.. [DOI: 10.1101/2022.07.08.499173] [Reference Citation Analysis]
14 Ortiz-rivera J, Albors A, Kucheryavykh Y, Harrison JK, Kucheryavykh L. The Dynamics of Tumor-Infiltrating Myeloid Cell Activation and the Cytokine Expression Profile in a Glioma Resection Site during the Post-Surgical Period in Mice. Brain Sciences 2022;12:893. [DOI: 10.3390/brainsci12070893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Larkin CJ, Arrieta VA, Najem H, Li G, Zhang P, Miska J, Chen P, James CD, Sonabend AM, Heimberger AB. Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics Era. Front Immunol 2022;13:907605. [DOI: 10.3389/fimmu.2022.907605] [Reference Citation Analysis]
16 Koh L, Novera W, Lim SW, Chong YK, Pang QY, Low D, Ang BT, Tang C. Integrative multi-omics approach to targeted therapy for glioblastoma. Pharmacol Res 2022;182:106308. [PMID: 35714825 DOI: 10.1016/j.phrs.2022.106308] [Reference Citation Analysis]
17 Ravi VM, Will P, Kueckelhaus J, Sun N, Joseph K, Salié H, Vollmer L, Kuliesiute U, von Ehr J, Benotmane JK, Neidert N, Follo M, Scherer F, Goeldner JM, Behringer SP, Franco P, Khiat M, Zhang J, Hofmann UG, Fung C, Ricklefs FL, Lamszus K, Boerries M, Ku M, Beck J, Sankowski R, Schwabenland M, Prinz M, Schüller U, Killmer S, Bengsch B, Walch AK, Delev D, Schnell O, Heiland DH. Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma. Cancer Cell 2022;40:639-655.e13. [PMID: 35700707 DOI: 10.1016/j.ccell.2022.05.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
18 Zheng B, Fang L. Spatially resolved transcriptomics provide a new method for cancer research. J Exp Clin Cancer Res 2022;41:179. [PMID: 35590346 DOI: 10.1186/s13046-022-02385-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Rozowsky JS, Meesters-Ensing JI, Lammers JAS, Belle ML, Nierkens S, Kranendonk MEG, Kester LA, Calkoen FG, van der Lugt J. A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies. Front Immunol 2022;13:864423. [PMID: 35464481 DOI: 10.3389/fimmu.2022.864423] [Reference Citation Analysis]
20 Akhlaghdoust M, Tavakolpour S, Davoodi P, Rahmani S, Zali A, Rezaei N. Signaling Pathways in Neurological Cancers. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_14] [Reference Citation Analysis]